Journal
JOURNAL OF NEUROLOGY
Volume 258, Issue 3, Pages 353-358Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s00415-010-5797-8
Keywords
Multiple sclerosis; Vitamin D binding protein; Cerebrospinal fluid; Disease course
Categories
Ask authors/readers for more resources
Multiple sclerosis (MS) is the most common demyelinating disease of the central nervous system (CNS). A growing body of evidence supports a role for vitamin D in MS aetiology. Vitamin D binding protein (DBP) is the major plasma carrier of vitamin D metabolites and genetic differences in DBP gene have been found to influence vitamin D levels. We review here evidence supporting a role of DBP in MS. Several recent studies show that DBP levels in the cerebrospinal fluid correlate with MS course, being lower during relapses and higher in the secondary progressive phase. Further studies are needed to elucidate the potential use of DBP as a biological marker of MS course, but may be of use given the current lack of diagnostic tools for the prediction of MS development and progression.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available